Paul Chaplin, Bavarian Nordic CEO
With record-breaking mpox vaccine sales, Bavarian Nordic buys trio of shots from Emergent for $270M cash
Bavarian Nordic is putting some of its mpox vaccine windfalls to use, wagering $270 million in cash to acquire three travel vaccines — two of which …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
